CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net loss	$ (623)	$ (3,116)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	40,714	39,432
Interest expense related to amortization of debt issue costs and debt discount	1,699	4,999
Stock-based compensation	1,576	1,267
Deferred income taxes	429	223
Net loss (gain) on disposition of property, plant and equipment	(84)	(726)
Gain on sale of discontinued operations, net of income taxes	(3,032)	(2,158)
Asset impairments	1,466	0
Net loss of unconsolidated joint ventures	286	0
Gain on convertible debt repayments	0	(35)
Decrease in trade receivables	3,531	1,066
Increase in inventories	(8,639)	(2,931)
Decrease in accounts payable and accrued liabilities	(27,216)	(25,748)
Other changes in operating assets and liabilities, net	(4,910)	(4,403)
Net cash provided by (used in) operating activities	5,197	7,870
Cash flows from investing activities:
Payments for acquisitions	(88,579)	(43,250)
Payments for investments in unconsolidated joint ventures	(1,450)	0
Purchase of property, plant and equipment	(25,367)	(21,546)
Proceeds from disposition of property, plant and equipment	864	855
Proceeds from sale of discontinued operations	4,666	4,813
Net decrease (increase) in long-term receivables and deposits	7,673	(694)
Net change in other assets	(2,876)	(430)
Net cash used in investing activities	(105,069)	(60,252)
Cash flows from financing activities:
Net proceeds from issuance of common stock	0	77,957
Net proceeds from issuance of long-term debt	146,200	0
Payments on long-term debt	(7,792)	(39,476)
Employee stock purchases	612	609
Net cash provided by financing activities	139,020	39,090
Net increase (decrease) in cash and cash equivalents	39,148	(13,292)
Cash and cash equivalents, beginning of period	75,316	53,782
Cash and cash equivalents, end of period	$ 114,464	$ 40,490